Baseline demographic characteristics and clinical variables of enrolled patients

VariablesTraining Cohort (n = 161)Validation Cohort (n = 175)P Value
Good Outcome (n = 110) mRS (0–2)Poor Outcome (n = 51) mRS (3–6)P ValueGood Outcome (n = 98) mRS (0–2)Poor Outcome (n = 77) mRS (3–6)P Value
Age (mean) (yr)65.7 (SD, 11.65)63.76 (SD, 13.51).4566.76 (SD, 12.45)66.96 (SD, 13.28).83.20
Male (No.) (%)69 (62.73)34 (66.67).7668 (69.39)48 (62.34).41.66
History (No.) (%)
 Hypertension90 (81.82)41 (80.39)1.0071 (72.45)54 (70.13).87.05
 Hyperlipidemia36 (32.73)16 (31.37)1.0023 (23.47)25 (32.47).25.33
 Diabetes34 (30.91)19 (37.25).5425 (25.51)24 (31.17).51.33
 Smoking21 (19.09)15 (29.41).2123 (23.47)16 (20.78).81.99
 Atrial fibrillation74 (67.27)24 (47.06).0269 (70.41)42 (54.55).05.63
 Coronary heart disease22 (20.00)7 (13.73).4616 (16.33)14 (18.18).90.83
NIHSS score (mean)14.26 (SD, 8.45)14.51 (SD, 8.24).9214.32 (SD, 7.57)15.27 (SD, 6.90).19.64